Pentwater Capital Management Adds $41M in Surgery Partners, Inc. ($SGRY)

Key Points

  • Pentwater Capital Management changed its Surgery Partners, Inc. ($SGRY) stake by 26.55% last quarter, boosting to 12,655,000 shares worth $193.75 million.
  • Wall Street's consensus rating on $SGRY is Buy and an average price target of $18.73.
  • $SGRY last traded around $15.31.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Pentwater Capital Management increased its position in Surgery Partners, Inc. ($SGRY) by 26.55% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,655,000 shares of Surgery Partners, Inc. after buying 2,655,000 shares during the quarter. Pentwater Capital Management's holdings in Surgery Partners, Inc. were worth $193.75 million as of its most recent filing.

Surgery Partners, Inc. Stock Up 11.8%

Shares of Surgery Partners, Inc. ($SGRY) traded around $15.31 on Saturday, up 11.8% for the day.

Last price$15.31
Market cap$1.82B
Forward P/E22.14
Beta1.94
52-week low$11.41
52-week high$23.44
50-day MA$15.44
200-day MA$14.78
Current ratio1.95
Quick ratio1.44
Debt-to-equity1.17

Surgery Partners, Inc. Earnings

EPS (ttm)-$0.69
Revenue (ttm)$3.37B
Revenue growth2.70%
Net margin-2.63%
Return on equity2.32%
Next earningsNov 9, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$18.73
High target$24
Low target$14
Analysts covering11

About Surgery Partners, Inc.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

ExchangeNasdaqGS
SectorHealthcare
IndustryMedical Care Facilities
HeadquartersBrentwood, TN
CEOMr. J. Eric Evans
Employees16,000

Get Surgery Partners, Inc. alerts

New 13F filings, insider trades, and analyst moves on $SGRY, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.